- News & Analysis
- Home
- Latest News
- Reports
- Podcasts
- The CVC Funding Round Database
- The CVC Directory
- University
- Video
- Subscribe
- Newsletters
- Job Postings
- Events
Page 930
Cytochroma exits to Opko
Opko will pay $100m initially using its shares and the rest in performance fees.
Jan 14, 2013Labcyte hears GE's money
GE Healthymagination, part of GE Ventures, led the D round as a new investor
Jan 14, 2013Skilled Care Pharmacy gains Link-Age
Link-Age, a US group backed by several non profit assisted living centres, has invested in senior citizen focused pharmaceutical retailer Skilled Care Pharmacy in return for an equity stake.
Jan 14, 2013Spinomix diagnoses Debiopharm investment
Founded in 2004 and located at the Swiss Federal Institute of Technology of Lausanne (EPFL), Lausanne, Spinomix helps with sample preparation of biological materials.
Jan 11, 2013Ascension climbs to third fund
Three new limited partners will join CHV III, including Intermountain Healthcare of Salt Lake City, Utah, and Decatur Memorial Hospital of Decatur, Illionois.
Jan 10, 2013Foundation Medicine taps into $13.5m
The company previously held a $42.5m first close on the round, including from Roche Venture Fund, WuXi Corporate Venture Fund, and Google Ventures.
Jan 10, 2013Run3D finds its legs with Oxford
Bio-engineering company Run3D spins-out from the University of Oxford.
Jan 9, 2013Stack and de Winter join GE
Risa Stack and Alex de Winter have joined corporate venturing healthcare investment programme GE Healthymagination.
Jan 8, 2013Fidelity optimises Kyruus
US-based data start-up for hospitals and health systems Kyruus raises $11m in a series B round led by Lux Capital, which was joined by Fidelity Biosciences, Venrock and Highland Capital Partners.
Jan 7, 2013Solstice receives $18m for RNA
US-based biotech startup Solstice Biologics, which has an exclusive licence with University of California, San Diego, receives $18m series A investment.
Jan 7, 2013About us
GCV provides the global corporate venturing community and their ecosystem partners with the information, insights and access needed to drive impactful open innovation. Across our three services - News & Analysis, Community & Events, and the GCV Institute - we create a network-rich environment for global innovation and capital to meet and thrive. At the heart of our community sits our membership, providing privileged access to all our services and resources.
Navigation
test regLogin
Not yet subscribed?
We use cookies to enhance your browsing experience and analyse our traffic. By clicking "Accept All", you consent to our use of cookies. Accept Read MorePrivacy & Cookies PolicyPrivacy Overview
This website uses cookies to improve your experience while you navigate through the website. Out of these, the cookies that are categorized as necessary are stored on your browser as they are essential for the working of basic functionalities of the website. We also use third-party cookies that help us analyze and understand how you use this website. These cookies will be stored in your browser only with your consent. You also have the option to opt-out of these cookies. But opting out of some of these cookies may affect your browsing experience.Necessary cookies are absolutely essential for the website to function properly. This category only includes cookies that ensures basic functionalities and security features of the website. These cookies do not store any personal information.Any cookies that may not be particularly necessary for the website to function and is used specifically to collect user personal data via analytics, ads, other embedded contents are termed as non-necessary cookies. It is mandatory to procure user consent prior to running these cookies on your website.


